OliX Pharmaceuticals, Inc (KOSDAQ:226950)
185,300
-11,200 (-5.70%)
Apr 28, 2026, 3:30 PM KST
269.12% (1Y)
| Market Cap | 3.76T |
| Revenue (ttm) | 14.67B |
| Net Income (ttm) | -15.74B |
| Shares Out | 20.30M |
| EPS (ttm) | -800.46 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 256,869 |
| Average Volume | 285,569 |
| Open | 188,900 |
| Previous Close | 196,500 |
| Day's Range | 182,200 - 190,000 |
| 52-Week Range | 34,500 - 217,000 |
| Beta | 0.56 |
| RSI | 54.96 |
| Earnings Date | Mar 27, 2026 |